For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs.

Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...

Tianyin Pharmaceutical Co., Inc. (TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other ...

This leaflet answers some common questions about GLICLAZIDE MR VIATRIS. It does not contain all the available information Reading this leaflet does not take the place of talking to your doctor, ...

Lotus Pharmaceuticals, a Chinese drug developer, announced that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the ...